Moreover, in a recent study, the type of stroke has been indicated as well, citing an increased risk of haemorrhagic stroke under a month from discontinuation of ranibizumab exposure, which was possibly owing to the delayed effect of VEGF (Jeon et al., 2021). The gene discussed is VEGFA; the disease is stroke disorder.